drug · gene
pexastimogene devacirepvec
Phase 2updated 3mo agoby Sillajen Biotherapeutics🔗 ChEMBL
Phase 2community read0 votes
Gene drug with a maximum clinical stage of Phase 3 (across all indications), with 11 investigational indications.
targets
Granulocyte-macrophage colony-stimulating factor
all catalysts(0)
nothing on the calendar yet
Trials studying pexastimogene devacirepvec
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 8m ago
Found something off?
comments(0)
5-min edit window · permanent after that